Wed, January 25, 2012
[ Wed, Jan 25th 2012 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of TranS1 Inc.
[ Wed, Jan 25th 2012 ] - Market Wire
Gilead start een Fase 2 klinisch onderzoek voor d .. n lage-dosis nieuwe prodrug van Tenofovir voor de
[ Wed, Jan 25th 2012 ] - Market Wire
Gilead avvia una sperimentazione clinica di Fase .. 340, un nuovo profarmaco di tenofovir a basso dos
[ Wed, Jan 25th 2012 ] - Market Wire
Gilead inicia ensayo clnico de Fase 2 que evala G .. e baja dosis de tenofovir para el tratamiento del
[ Wed, Jan 25th 2012 ] - Market Wire
Harwood Feffer LLP Announces Investigation of Illumina Inc.
[ Wed, Jan 25th 2012 ] - Market Wire
Thoratec Schedules Fourth Quarter Conference Call, Webcast
[ Wed, Jan 25th 2012 ] - Market Wire
Investigation of Chemed Corporation Shareholder Claims by Goldfarb Branham Law Firm LLP
[ Wed, Jan 25th 2012 ] - Market Wire
ZELTIQ spant rechtszaak aan tegen Clinipro wegens patentinbreuk
[ Wed, Jan 25th 2012 ] - Market Wire
Neurocrine Biosciences Announces The FDA Has Gran .. t Track Designation For VMAT2 Inhibitor NBI-98854
[ Wed, Jan 25th 2012 ] - Market Wire
Medtronic and Guided Therapeutics Poised for Growth
[ Wed, Jan 25th 2012 ] - Market Wire
Digirad Receives CE Mark Approval for Advanced, Solid-State Cardius(R) X-ACT Imaging System
[ Wed, Jan 25th 2012 ] - Market Wire
ZELTIQ Initiates Patent Infringement Lawsuit Against Clinipro
[ Wed, Jan 25th 2012 ] - Market Wire
Dados Clnicos para o Estudo da DURABILIDADE II Apresentado na ISET 2012
[ Wed, Jan 25th 2012 ] - Market Wire
Donnes cliniques pour l'tude DURABILITY II prsente lors de l'ISET 2012
[ Wed, Jan 25th 2012 ] - Market Wire
FDA actualiseert TYSABRI (natalizumab) label en v .. s antilichaam status toe als een PML risicofactor
[ Wed, Jan 25th 2012 ] - Market Wire
Marina Biotech Starts Cohort 2 of Its Phase 1b START-FAP Clinical Trial of CEQ508
[ Wed, Jan 25th 2012 ] - Market Wire
DaVita Acquires Majority Stake in NephroLife India
[ Wed, Jan 25th 2012 ] - Market Wire
Cord Blood America Reports that Umbilical Cord Bl .. Used in Experimental Effort to Treat Type 1 Diabe
Tue, January 24, 2012
[ Tue, Jan 24th 2012 ] - Market Wire
Quarterly Report I 11/12
[ Tue, Jan 24th 2012 ] - Market Wire
Codexis Announces CFO Departure
[ Tue, Jan 24th 2012 ] - Market Wire
Mylan to Host Investor Day on Feb. 21, 2012, in New York City
[ Tue, Jan 24th 2012 ] - Market Wire
Cleveland BioLabs Announces Management Reorganization
[ Tue, Jan 24th 2012 ] - Market Wire
Critical Outcome Technologies Inc. Initiates Preclinical Testing of AML Drug Candidates
[ Tue, Jan 24th 2012 ] - Market Wire
Sirona Biochem Appoints Sean Cunliffe to Chief Business Officer and Board of Directors
[ Tue, Jan 24th 2012 ] - Market Wire
Booming Stem Cell Market Benefits Advanced Cell Technology and Neostem
[ Tue, Jan 24th 2012 ] - Market Wire
Breakthrough Therapy Using Cord Blood Banking Driving Stem Cell Industry
[ Tue, Jan 24th 2012 ] - Market Wire
Echo Therapeutics Initiates Clinical Trials of its Symphony tCGM System in Critical Care Patients
[ Tue, Jan 24th 2012 ] - Market Wire
Adipose Stem Cell Heart Attack Trial Data Publish .. College of Cardiology;; Cytori's APOLLO T
[ Tue, Jan 24th 2012 ] - Market Wire
Spectranetics Strengthens Peripheral Vascular Por .. a Partnership to Distribute the TAPASa" Catheter
[ Tue, Jan 24th 2012 ] - Market Wire
BioLineRx Signs Exclusive License Agreement for BL-8020, an Oral Treatment for Hepatitis C
[ Tue, Jan 24th 2012 ] - Market Wire
PDL BioPharma Announces 2012 Regular Quarterly Dividends
[ Tue, Jan 24th 2012 ] - Market Wire
Quest Diagnostics Increases Share Repurchase Authority by $1 Billion
[ Tue, Jan 24th 2012 ] - Market Wire
Covidien verffentlicht klinische Daten ber Plaque-Exzision zur Behandlung kalzifizierter Lsionen
[ Tue, Jan 24th 2012 ] - Market Wire
TPI to Hold 2011 Shareholder Annual Meeting on April 11, 2012 in New York City
[ Tue, Jan 24th 2012 ] - Market Wire
OncoSec to Present at World Cancer Immunotherapy Conference
[ Tue, Jan 24th 2012 ] - Market Wire
Dhr. Richard W. Barker wordt lid Raad van Bestuur van Celgene Corporation
Mon, January 23, 2012
[ Mon, Jan 23rd 2012 ] - Market Wire
Revoici la dpche corrige : Celgene Corporation li .. W. Barker, D. Phil., son conseil d'administration
[ Mon, Jan 23rd 2012 ] - Market Wire
Celgene Corporation incorpora a su Consejo de Administracin al Dr. Richard W. Barker
[ Mon, Jan 23rd 2012 ] - Market Wire
Bronstein, Gewirtz & Grossman, LLC Investigates Columbia Laboratories, Inc.
[ Mon, Jan 23rd 2012 ] - Market Wire
Fresh Start Private Renews Advertising Agreement With Clear Channel Los Angeles Until 2013
[ Mon, Jan 23rd 2012 ] - Market Wire
UnitedHealth Group, The Goldman Sachs, Tiffany & Company, News Corporation and School Specialty
[ Mon, Jan 23rd 2012 ] - Market Wire
Verisante Aura Clinical Study Data Analysis Presented at SPIE
[ Mon, Jan 23rd 2012 ] - Market Wire
OPKO Health Acquires Next Generation Prostate Cancer Tests
[ Mon, Jan 23rd 2012 ] - Market Wire
Aethlon Medical Establishes Extracorporeal Therapy Scientific Advisory Board
[ Mon, Jan 23rd 2012 ] - Market Wire
Medtronic Announces 510(k) Clearance for the Aqua .. SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery
[ Mon, Jan 23rd 2012 ] - Market Wire
Canada's First National Public Cord Blood Bank Ad .. ThermoGenesis BioArchive Cryopreservation System
[ Mon, Jan 23rd 2012 ] - Market Wire
MyMedicalRecords to Introduce Mobile Phone and Tablet App at HIMSS
[ Mon, Jan 23rd 2012 ] - Market Wire
Boston Scientific Announces Favorable Ruling in Patent Infringement Case
[ Mon, Jan 23rd 2012 ] - Market Wire
Amarantus BioSciences Licenses Parkinsonas Diseas .. ostic Biomarker Test from Power3 Medical Products
[ Mon, Jan 23rd 2012 ] - Market Wire
The Medicines Company Settles Angiomax(R) (Bivali .. udin) Patent Litigations With App Pharmaceuticals
[ Mon, Jan 23rd 2012 ] - Market Wire
EntreMed Secures $10 Million Strategic Financing
[ Mon, Jan 23rd 2012 ] - Market Wire
Marina Biotech Receives Notice of Acceptance for .. g Its Unlocked Nucleobase Analog (UNA) Technology
[ Mon, Jan 23rd 2012 ] - Market Wire
BioLife Solutions Adds Clinical and Commercialization Experts to Scientific Advisory Board
[ Mon, Jan 23rd 2012 ] - Market Wire
PAREXEL Expands Alliance Network to Support Early .. lishes Collaboration With University Hospitals Br
Sun, January 22, 2012
[ Sun, Jan 22nd 2012 ] - Market Wire
Helix BioPharma Corp. Responds to Dissident Proxy .. ion With the January 30, 2012 Shareholder Meeting
Sat, January 21, 2012
[ Sat, Jan 21st 2012 ] - Market Wire
L'FDA aggiorna l'etichetta del TYSABRI (natalizum .. egli anticorpi anti-JCV come fattore di rischio d
[ Sat, Jan 21st 2012 ] - Market Wire
FDA aktualisiert Produktinformationen fr TYSABRI .. des JC-Virus-Antikrperstatus als Risikofaktor fr
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l' .. zumab) pour y inclure le statut daanticorps anti-
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. de TYSABRI (natalizumab) pour y inclure le statut
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;tiquetage de TYSABRI (natalizumab) p
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;tiquetage de TYSABRI (na
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;tiquetage de TYS
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;tiquetage de
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;tiquetag
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;tiqu
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&
[ Sat, Jan 21st 2012 ] - Market Wire
La Food and Drug Administration (FDA) met jour l& .. ;;;;;;;;;;;;&
Fri, January 20, 2012
[ Fri, Jan 20th 2012 ] - Market Wire
Select Medical Holdings Corporation to Announce F .. d Full Year 2011 Results on Thursday, February 23
[ Fri, Jan 20th 2012 ] - Market Wire
FDA Advisory Committee Declines to Recommend Appr .. Gel 8% for the Reduction of Risk of Preterm Birth
[ Fri, Jan 20th 2012 ] - Market Wire
FDA Updates TYSABRI (natalizumab) Label to Includ .. nti-JC Virus Antibody Status as a PML Risk Factor
[ Fri, Jan 20th 2012 ] - Market Wire
Bestuursvoorzitter van Covidien gekozen tot Voorzitter van de Raad
[ Fri, Jan 20th 2012 ] - Market Wire
Waters and NIBRT Complete Work on World's First UPLC Glycan Database
[ Fri, Jan 20th 2012 ] - Market Wire
Sequenom Prices Public Offering of Common Stock
[ Fri, Jan 20th 2012 ] - Market Wire
Amerigroup Corporation to Discuss Fourth Quarter Earnings on February 17
[ Fri, Jan 20th 2012 ] - Market Wire
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
[ Fri, Jan 20th 2012 ] - Market Wire
Hartford Hospital Selected as a Hansen Medical "C .. llence" for Sensei(R) X Robotic Catheter Platform
[ Fri, Jan 20th 2012 ] - Market Wire
Genomic Health Presents Results From First Clinic .. ncotype DX Colon Cancer at the 2012 Gastrointesti
[ Fri, Jan 20th 2012 ] - Market Wire
Insmed Incorporated Provides Corporate Update
[ Fri, Jan 20th 2012 ] - Market Wire
INVO Bioscience Announces Approval of INVOcell by Brazil's ANVISA
[ Fri, Jan 20th 2012 ] - Market Wire
Allos Therapeutics Receives Negative Opinion from the CHMP on FOLOTYN
[ Fri, Jan 20th 2012 ] - Market Wire
Director general de Covidien designado presidente del Directorio
[ Fri, Jan 20th 2012 ] - Market Wire
Covidien CEO Elected Chairman of the Board
[ Fri, Jan 20th 2012 ] - Market Wire
Covidien: amministartore delegato eletto presidente del consiglio d'amministrazione
[ Fri, Jan 20th 2012 ] - Market Wire
Le PDG de Covidien est lu prsident du conseil daadministration
[ Fri, Jan 20th 2012 ] - Market Wire
Covidien-CEO zum Chairman of the Board gewhlt
Thu, January 19, 2012
[ Thu, Jan 19th 2012 ] - Market Wire
LaAgenzia per gli Alimenti e i Medicinali statuni .. tration, FDA) approva delle nuove formulazioni di
[ Thu, Jan 19th 2012 ] - Market Wire
Cannabis Science Updates Second Medical Cannabis .. Squamous Cell Carcinoma Photo-documents Cannabis
[ Thu, Jan 19th 2012 ] - Market Wire
Holzer Holzer & Fistel, LLC Announces Investigati .. Breaches of Fiduciary Duty by Certain Officers an
[ Thu, Jan 19th 2012 ] - Market Wire
Tenet Announces New Agreement with Blue Cross and Blue Shield of Illinois
[ Thu, Jan 19th 2012 ] - Market Wire
Mylan Launches Innovative Version of Antiepileptic Drug Levetiracetam
[ Thu, Jan 19th 2012 ] - Market Wire
Novo Nordisk Named to FORTUNE'S '100 Best Companies to Work For' List for Fourth Consecutive Year
[ Thu, Jan 19th 2012 ] - Market Wire
Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock
[ Thu, Jan 19th 2012 ] - Market Wire
ShangPharma Announces Milestone Achievement in Research Partnership with Hengrui
[ Thu, Jan 19th 2012 ] - Market Wire
Magellan Health Services and Phoenix Health Plan Announce Joint Venture Development Agreement
[ Thu, Jan 19th 2012 ] - Market Wire
Community Health Systems, Inc. Announces Its Inte .. ent of Its Existing Credit Agreement and Extensio
[ Thu, Jan 19th 2012 ] - Market Wire
ARCA biopharma Announces Additional Patent Issued .. ment with Bucindolol Based on Genotype of Patient
[ Thu, Jan 19th 2012 ] - Market Wire
OncoGenex Announces Presentation of OGX-427 Data at the ASCO 2012 Genitourinary Cancers Symposium
[ Thu, Jan 19th 2012 ] - Market Wire
Nordion Enters Six-Year Cobalt-60 Supply Agreement with Synergy Health
[ Thu, Jan 19th 2012 ] - Market Wire
Mindray Medical to Exhibit at Arab Health 2012 in Dubai from January 23-26
[ Thu, Jan 19th 2012 ] - Market Wire
Implant Sciences' Quantum Sniffer QS-H150 Deployed at Major International Bank in Middle East
[ Thu, Jan 19th 2012 ] - Market Wire
Uroplasty to Issue Third Quarter 2012 Financial Results on January 26, 2012
[ Thu, Jan 19th 2012 ] - Market Wire
Adeona Announces Initiation of Phase II Clinical .. " for Cognitive Dysfunction in Multiple Sclerosis
[ Thu, Jan 19th 2012 ] - Market Wire
Kraig Biocraft Laboratories Announces New CEO Interview
Wed, January 18, 2012
[ Wed, Jan 18th 2012 ] - Market Wire
Astellas und XenoPort geben japanische Zulassung .. ite-Tabletten gegen Restless-Legs-Syndrom bekannt
[ Wed, Jan 18th 2012 ] - Market Wire
Bond Labs Launches Innovative New Product Stack
[ Wed, Jan 18th 2012 ] - Market Wire
Brain Cancer Patient Receives First TrueBeam STx .. ment in Asia at BGS Global Hospitals in Bangalore
[ Wed, Jan 18th 2012 ] - Market Wire
Astellas e XenoPort annunciano l'approvazione del .. per il trattamento della sindrome delle gambe se
[ Wed, Jan 18th 2012 ] - Market Wire
Jazz Pharmaceuticals and Azur Pharma Combine to Create Jazz Pharmaceuticals plc
[ Wed, Jan 18th 2012 ] - Market Wire
Cynosure to Host Fourth-Quarter 2011 Financial Results Conference Call on February 14
[ Wed, Jan 18th 2012 ] - Market Wire
Comprehensive Care Corp. (CHCR) Completes Its Network Across Puerto Rico
[ Wed, Jan 18th 2012 ] - Market Wire
Prestige Brands, Inc. Announces Offering of $290 Million Senior Notes
[ Wed, Jan 18th 2012 ] - Market Wire
Gilead Sciences perfeziona laacquisizione di Pharmasset, Inc.
[ Wed, Jan 18th 2012 ] - Market Wire
Abschluss der bernahme von Pharmasset, Inc., durch Gilead Sciences
[ Wed, Jan 18th 2012 ] - Market Wire
Gilead Sciences completa adquisicin de Pharmasset, Inc.
[ Wed, Jan 18th 2012 ] - Market Wire
Biomerica Announces Second Quarter Financial Results
[ Wed, Jan 18th 2012 ] - Market Wire
Given Imaging to Host Fourth Quarter and Full-Year 2011 Financial Results Conference Calls
[ Wed, Jan 18th 2012 ] - Market Wire
Soligenix Demonstrates Robust Stability Results with its SGX204 Anthrax Vaccine
[ Wed, Jan 18th 2012 ] - Market Wire
Bioline Introduces HyperPAGE II Broad Range Prestained Protein Marker
[ Wed, Jan 18th 2012 ] - Market Wire
MedPro Safety Products to Participate in Key European, US Industry Conferences
[ Wed, Jan 18th 2012 ] - Market Wire
OncoSec Provides Company Update and Announces 2012 Goals
[ Wed, Jan 18th 2012 ] - Market Wire
Perceptive Informatics Medical Imaging Services Receive Top Ratings
Tue, January 17, 2012
[ Tue, Jan 17th 2012 ] - Market Wire
Gilead Sciences Completes Acquisition of Pharmasset, Inc.
[ Tue, Jan 17th 2012 ] - Market Wire
The Medicines Company's Cangrelor Bridge Trial Pu .. n the Journal of the American Medical Association
[ Tue, Jan 17th 2012 ] - Market Wire
Life Technologies Sets 4th Quarter and Full Year .. rnings Release Date for Tuesday, February 7, 2012
[ Tue, Jan 17th 2012 ] - Market Wire
Graymark Healthcare Partners With Emory Universit .. anta, Georgia to Deliver Comprehensive Sleep Care
[ Tue, Jan 17th 2012 ] - Market Wire
Johnson & Johnson to Host Analyst Meeting to Disc .. urth-Quarter and Full-Year 2011 Financial Results
[ Tue, Jan 17th 2012 ] - Market Wire
Johnson amp;; Johnson to Host Analyst Meet .. urth-Quarter and Full-Year 2011 Financial Results
[ Tue, Jan 17th 2012 ] - Market Wire
Alnylam Files Patent Infringement Suit Against Tekmira
[ Tue, Jan 17th 2012 ] - Market Wire
Cleveland BioLabs Publishes Manuscript on New Radiation Countermeasure CBLB613
[ Tue, Jan 17th 2012 ] - Market Wire
Cytomedix Appoints Cathryn Hope as Vice President of Marketing
[ Tue, Jan 17th 2012 ] - Market Wire
ISTA Pharmaceuticals Announces Adoption of a Replacement Stockholders Rights Plan
[ Tue, Jan 17th 2012 ] - Market Wire
Palatin Technologies Receives $1.1 Million From Sale of New Jersey State Tax Credits
[ Tue, Jan 17th 2012 ] - Market Wire
MAP Pharmaceuticals Appoints W. James O'Shea to Board of Directors
[ Tue, Jan 17th 2012 ] - Market Wire
Akorn Provides Financial Guidance for 2012
[ Tue, Jan 17th 2012 ] - Market Wire
Medivation and Pfizer Announce Results From Phase .. 3 Concert Trial of Dimebon in Alzheimer's Disease
[ Tue, Jan 17th 2012 ] - Market Wire
Illumina to Announce Fourth Quarter and Fiscal Ye .. 11 Financial Results on Tuesday, January 31, 2012
[ Tue, Jan 17th 2012 ] - Market Wire
Health Management Associates, Inc. Provides Addit .. to Recently Announced General Counsel Resignation
[ Tue, Jan 17th 2012 ] - Market Wire
OncoSec Medical President and CEO Contributes to Drug Discovery News
[ Tue, Jan 17th 2012 ] - Market Wire
PAREXEL Appoints Former Senior FDA Official David .. er to Global Team of Strategic Compliance Experts
Mon, January 16, 2012
[ Mon, Jan 16th 2012 ] - Market Wire
ISTA's Board of Directors to Review Valeant's Rev .. s Part of Its Ongoing Review of Strategic Options
[ Mon, Jan 16th 2012 ] - Market Wire
Array BioPharma's Chief Executive Officer Robert E. Conway Resigns
[ Mon, Jan 16th 2012 ] - Market Wire
Life Technologies Partners With DaAn Gene to Deve .. ommercialize Molecular Diagnostic Assays in China
[ Mon, Jan 16th 2012 ] - Market Wire
Boston Scientific Epica" Stent Demonstrates Positive Clinical Outcomes in Orion Trial
[ Mon, Jan 16th 2012 ] - Market Wire
Covidien contre-indique lautilisation de Duet TRS .. irurgie thoracique et procde un rappel volontaire
[ Mon, Jan 16th 2012 ] - Market Wire
Covidien kontraindiziert Duet TRSTM fr Thoraxchirurgie und startet freiwillige Rckrufaktion
[ Mon, Jan 16th 2012 ] - Market Wire
Luminex Corporation Fourth Quarter and Full Year .. 1 Earnings Release Scheduled for February 6, 2012
[ Mon, Jan 16th 2012 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Inves .. iduciary Duty by the Officers and Directors of Ch
[ Mon, Jan 16th 2012 ] - Market Wire
Sycamore Entertainment Group Inc. Acquires US Dis .. F THE STORM, Starring Academy Award Winner Geoffr
[ Mon, Jan 16th 2012 ] - Market Wire
Questcor Pharmaceuticals Responds to Questions From Investor Blog
[ Mon, Jan 16th 2012 ] - Market Wire
Covidien contraindica el uso del sistema Duet TRS .. a e implementa su retirada voluntaria del mercado
[ Mon, Jan 16th 2012 ] - Market Wire
Covidien contraindica o uso de Duet TRSTM para cirurgia torcica e convoca um recall voluntrio
[ Mon, Jan 16th 2012 ] - Market Wire
Covidien geeft contra-indicatie voor gebruik van .. rurgie, Het voert een vrijwillige terugroeping ui
[ Mon, Jan 16th 2012 ] - Market Wire
MSA Declares First Quarter Dividend
[ Mon, Jan 16th 2012 ] - Market Wire
Covidien mette in guardia contro lauso del Duet T .. hirurgia toracica e ne attua il ritiro volontario
[ Mon, Jan 16th 2012 ] - Market Wire
Covidien Contraindicates the Use of Duet TRSTM for Thoracic Surgery, Implements a Voluntary Recall
[ Mon, Jan 16th 2012 ] - Market Wire
Neogen Develops Simple, Precise Test for Mold Toxin Zearalenone
[ Mon, Jan 16th 2012 ] - Market Wire
Palatin Technologies to Present at BOCEMb, Noble .. Capital Markets' Eighth Annual Equity Conference
Fri, January 13, 2012
[ Fri, Jan 13th 2012 ] - Market Wire
ZOLL Medical Corporation First Quarter Conference Call Notification
[ Fri, Jan 13th 2012 ] - Market Wire
Federman &;; Sherwood Announces That a .. it Has Been Filed Against Chemed Corporation (NYS
[ Fri, Jan 13th 2012 ] - Market Wire
Life Technologies Announces Redemption of 1.5% Convertible Senior Notes Due 2024
[ Fri, Jan 13th 2012 ] - Market Wire
January 30, 2012
[ Fri, Jan 13th 2012 ] - Market Wire
Prestige Brands, Inc. Announces Proposed Offering of $290 Million Senior Notes
[ Fri, Jan 13th 2012 ] - Market Wire
The Law Firm of Levi &;; Korsinsky, LLP .. of Breaches of Fiduciary Duty by the Board of In
[ Fri, Jan 13th 2012 ] - Market Wire
Critical Alerts for Celgene, DirecTV, Goldcorp, T .. , and Coinstar Released by Seven Summits Research
[ Fri, Jan 13th 2012 ] - Market Wire
Humana, Guess?, Tractor Supply Company, Chevron and PVH
[ Fri, Jan 13th 2012 ] - Market Wire
Omni Bio to Conduct New Human Clinical Trials
[ Fri, Jan 13th 2012 ] - Market Wire
A Forward Look, the Year Ahead -- Featured Research on Mylan Inc. and Cloud Peak Energy Inc.
[ Fri, Jan 13th 2012 ] - Market Wire
A Forward Look, the Year Ahead -- Featured Resear .. ion Pharmaceuticals, Inc. and Nektar Therapeutics
[ Fri, Jan 13th 2012 ] - Market Wire
Savient Pharmaceuticals Appoints Experienced Phar .. tive, David Veitch as President of Savient Europe
[ Fri, Jan 13th 2012 ] - Market Wire
Equity Research on Humana Inc. and WellPoint Inc. -- Healthcare Providers Continuing Momentum
[ Fri, Jan 13th 2012 ] - Market Wire
MYTHOS Trial of PLC's RenalGuard Article Published in JACC -- Cardiovascular Interventions
[ Fri, Jan 13th 2012 ] - Market Wire
Health Canada Grants Priority Review Status For N .. ission (NDS) For Cinryzea" (C1 Inhibitor [human])
[ Fri, Jan 13th 2012 ] - Market Wire
Seattle Genetics Announces Updates to ADCETRISa" Prescribing Information
[ Fri, Jan 13th 2012 ] - Market Wire
Covidien??Mark Trudeau??????????
[ Fri, Jan 13th 2012 ] - Market Wire
Covidien benoemt Mark Trudeau tot president van farmaceutisch segment
Thu, January 12, 2012
[ Thu, Jan 12th 2012 ] - Market Wire
Gilead Sciences voltooit aanbod voor alle uitstaande aandelen van Pharmasset, Inc.
[ Thu, Jan 12th 2012 ] - Market Wire
Cantel Medical Corp. Announces 3-for-2 Stock Split
[ Thu, Jan 12th 2012 ] - Market Wire
Block & Leviton LLP Investigates Possible Securit .. Claims Against Health Management Associates, Inc.
[ Thu, Jan 12th 2012 ] - Market Wire
Daxor Announces That the Mayo Clinic in Scottsdale, Arizona Acquires BVA-100 Blood Volume Analyzer
[ Thu, Jan 12th 2012 ] - Market Wire
Amerigroup Announces Proposed Add-On Offering of $50 Million of Its 7.50% Senior Notes due 2019
[ Thu, Jan 12th 2012 ] - Market Wire
Perrigo Wins Summary Judgment in Generic Mucinex Case
[ Thu, Jan 12th 2012 ] - Market Wire
Health Net Community Solutions Centers Offer Free .. llness Activities to Local Communities They Serve
[ Thu, Jan 12th 2012 ] - Market Wire
Obesity Drug Candidates From Arena Pharmaceuticals and Vivus Look to Make Big Splash in 2012
[ Thu, Jan 12th 2012 ] - Market Wire
WeedMaps Media Completes Acquisition of Leading Medicinal Cannabis Software Company
[ Thu, Jan 12th 2012 ] - Market Wire
Chief Operating Officer Tessie M. Che Departing Company
[ Thu, Jan 12th 2012 ] - Market Wire
Synta Pharmaceuticals and University of Toronto R .. ol Mechanism of Action Using Innovative Yeast-bas
[ Thu, Jan 12th 2012 ] - Market Wire
Kedem Pharmaceuticals Initiates Development of Sublingual Anti-Cancer Drug, Gleevec
[ Thu, Jan 12th 2012 ] - Market Wire
Covidien dona otro milln de dlares a un hospital de Hait
[ Thu, Jan 12th 2012 ] - Market Wire
MedPro Safety Products Strengthens Senior Management Team
[ Thu, Jan 12th 2012 ] - Market Wire
LCA-Vision to Present at the Noble Financial Eighth Annual Equity Conference
[ Thu, Jan 12th 2012 ] - Market Wire
Covidien doa mais US$ 1 milho para ajudar hospital haitiano
[ Thu, Jan 12th 2012 ] - Market Wire
Covidien spendet eine weitere Million US-Dollar fr Krankenhaus in Haiti
Wed, January 11, 2012
[ Wed, Jan 11th 2012 ] - Market Wire
Gilead Sciences Completes Tender Offer for All Outstanding Shares of Pharmasset, Inc.
[ Wed, Jan 11th 2012 ] - Market Wire
Covidien fait don daun million de dollars supplmentaires pour soutenir un h'pital hatien
[ Wed, Jan 11th 2012 ] - Market Wire
Vanguard Health Systems to Report Second Quarter Fiscal 2012 Results on February 1, 2012
[ Wed, Jan 11th 2012 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Launches an .. Securities Laws Violations by BioSante Pharmaceut
[ Wed, Jan 11th 2012 ] - Market Wire
MEDNAX 2011 Fourth Quarter Conference Call/Webcast Scheduled for Thursday, February 2, 2012

Covidien gibt vierteljhrliche Bardividende bekannt


//health-fitness.news-articles.net/content/2012/ .. n-gibt-vierteljhrliche-bardividende-bekannt.html
Published in Health and Fitness on Thursday, January 19th 2012 at 14:11 GMT by Market Wire   Print publication without navigation


DUBLIN--([ ])--Covidien plc (NYSE: COV) gab heute bekannt, dass sein Board of Directors eine vierteljhrliche Bardividende von 0,225 USD je Stammaktie beschlossen hat. Die Dividende ist am 22. Februar 2012 an alle Aktionre auszuzahlen, die per 30. Januar 2012 registriert sind.

BER COVIDIEN

Covidien ist ein weltweit fhrender Anbieter medizinischer Produkte, der innovative medizinische Lsungen fr bessere Behandlungsergebnisse entwickelt und durch klinische Fhrungsarbeit und Spitzenleistungen Werte schafft. Covidien produziert, vertreibt und betreut ein vielfltiges Sortiment branchenfhrender Produktlinien in drei Marktsegmenten: Medical Devices (Medizinische Gerte), Pharmaceuticals (Pharmazeutika) und Medical Supplies (Medizinbedarf). Im Bilanzjahr 2011 erzielte Covidien Umsatzerlse von 11,6 Milliarden US-Dollar. Das Unternehmen beschftigt weltweit 41.000 Mitarbeiter in mehr als 65 Lndern, und seine Produkte werden in mehr als 140 Lndern verkauft. Weitere Informationen ber unsere Geschftsttigkeit finden Sie unter [ www.covidien.com ].

Die Ausgangssprache, in der derOriginaltext verffentlicht wird, ist die offizielle und autorisierte Version. bersetzungen werdenzur besseren Verstndigungmitgeliefert.Nur die Sprachversion, die im Original verffentlicht wurde, ist rechtsgltig. Gleichen Sie deshalb bersetzungen mitder originalen Sprachversion der Verffentlichung ab.


Publication Contributing Sources